Elevated AIF-1 levels correlate with inflammatory adipocytes and obesity, while reduced AIF-1 promotes weight loss through regulation of monoamine oxidase A and decreased leptin/resistin production. Here, RETN is linked to obesity due to melanocortin 4 receptor deficiency.